Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Kathleen M. Schmeler"'
Autor:
Brian M. Slomovitz, Anca Chelariu-Raicu, Robert L. Coleman, David M. Gershenson, Judith K. Wolf, Karen H. Lu, Kathleen M. Schmeler
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 30(11)
IntroductionOverexpression of the epidermal growth factor receptor (EGFR) found in common subtypes of endometrial cancer has been associated with advanced stage disease and a poor prognosis. The purpose of this phase 2 study was to evaluate the effic
Autor:
Nyla Balakrishnan, Navdeep Pal, Andrea Milbourne, Shannon N. Westin, Lois M. Ramondetta, Kathleen M. Schmeler, Karen H. Lu, Larissa A. Meyer, Russell Broaddus, Diane C. Bodurka, Pedro T. Ramirez, Pamela T. Soliman, Diana L. Urbauer
Publikováno v:
Obstetrics & Gynecology. 131:109-116
Objective To assess efficacy of the levonorgestrel-releasing intrauterine device (LNG-IUD) for treatment of complex atypical hyperplasia or low-grade endometrial cancer. Methods This retrospective case series included all patients treated with the LN
Autor:
Renato Moretti Marques, Andressa Melina Severino Teixeira, Thomas J. Herzog, Kathleen M. Schmeler, Sergio Mancini Nicolau, Reitan Ribeiro
Publikováno v:
International Journal of Gynecology & Obstetrics. 137:78-85
Objective To develop a scoring system that guides surgical decision-making regarding the need to perform lymphadenectomy. Methods A retrospective study was performed of patients who underwent complete surgical staging of endometrial cancer between 20
Autor:
Revathy B. Iyer, Mila P. Salcedo, Camilo Jimenez, Ann H. Klopp, Patricia J. Eifel, Kathleen M. Schmeler, Anil K. Sood, Bryan Fellman, Anuja Jhingran
Publikováno v:
Cancer
Background: Advances in radiotherapy (RT) have led to improved oncologic outcomes for women with gynecologic cancers, however, the long-term effects and survivorship implications need further evaluation. The purpose of our study was to determine the
Autor:
Charlotte C. Sun, Nicole D. Fleming, Melinda S. Yates, Andrea Milbourne, Navdeep Pal, Alpa M. Nick, Jennifer K. Burzawa, Shannon N. Westin, Misty L. Woodall, Robert L. Coleman, Lois M. Ramondetta, Russell Broaddus, Karen H. Lu, Diane C. Bodurka, Ying Yuan, Kathleen M. Schmeler, Pamela T. Soliman, Diana L. Urbauer, Bryan Fellman
Publikováno v:
Am J Obstet Gynecol
Background The incidence of complex atypical hyperplasia and early-stage endometrioid endometrial cancer is increasing, in part owing to the epidemic of obesity, which is a risk factor tightly linked to the development of endometrial hyperplasia and
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 142:783-793
To assess how first course of treatment affects cancer-specific survival in women diagnosed with endometrial cancer younger than 50 years old.Public-use data from the Surveillance, Epidemiology, and End Results program were used. The study included 8
Autor:
Mark F. Munsell, Nicole D. Fleming, Ann H. Klopp, Pamela T. Soliman, Shannon N. Westin, Michael Frumovitz, Pedro T. Ramirez, Kathleen M. Schmeler, Alpa M. Nick, Ricardo dos Reis
Publikováno v:
International Journal of Gynecological Cancer. 25:1437-1444
Objectives To determine if the ratio of positive to negative lymph nodes, or lymph node ratio (LNR), is a prognostic variable in patients with node-positive endometrial cancer and the impact of adjuvant therapy on survival. Methods After institutiona
Publikováno v:
Gynecologic Oncology. 135:525-533
Objective To compare demographics, tumor characteristics, the first course of treatment, and cancer-specific survival of non-Hispanic White and Hispanic women with endometrial cancer. Methods We used public-use data from the Surveillance, Epidemiolog
Autor:
Pamela T. Soliman, Mauricio Borrero, Rene Pareja, Michael Frumovitz, Kathleen M. Schmeler, Gonzalo Angel, Carlos A. Buitrago, Pedro T. Ramirez, Alpa M. Nick, Ricardo dos Reis
Publikováno v:
Gynecologic Oncology. 125:326-329
To help determine whether global collaborations for prospective gynecologic surgery trials should include hospitals in developing countries, we compared surgical and oncologic outcomes of patients undergoing laparoscopic radical hysterectomy at a lar
Publikováno v:
Obstetrics & Gynecology. 119:423-426
The treatment of endometrial cancer in young women who desire future fertility poses several challenges. Oral progestin and progestin-releasing intrauterine devices (IUDs) have been shown to result in regression of endometrial hyperplasia and grade 1